Vitamin B12 is manufactured worldwide using bacteria grown in fermentation tanks, but current production yields are limited. According to Gram Research analysis, scientists are using genetic engineering and improved fermentation technology to make bacteria produce more B12 with fewer resources, which could significantly lower costs and increase global availability of this essential vitamin.
Vitamin B12 is essential for your body’s energy, brain function, and blood health, but most of the world’s supply comes from bacteria grown in factories. According to Gram Research analysis, scientists are working to improve how we manufacture B12 using special microbes and new fermentation techniques. A comprehensive review from the Tianjin Institute of Industrial Biotechnology examines the latest breakthroughs in making B12 production faster, cheaper, and more efficient. These innovations could make this vital vitamin more affordable and accessible to people worldwide, especially in developing countries where B12 deficiency remains a serious health concern.
Key Statistics
A 2026 review of vitamin B12 biomanufacturing from the Tianjin Institute of Industrial Biotechnology identified metabolic engineering of bacterial strains as a key strategy to overcome current production limitations and increase industrial B12 yields.
The global vitamin B12 market is driven by demand across pharmaceutical, animal feed, food fortification, and cosmetic industries, with cyanocobalamin serving as the primary industrial form due to its chemical stability.
Current industrial B12 production relies primarily on two bacterial strains—Pseudomonas denitrificans and Propionibacterium freudenreichii—though their relatively low production yields remain a major constraint for industry development.
Advanced fermentation technologies and metabolic engineering strategies show significant promise for reducing B12 production costs and improving manufacturing efficiency in the coming years.
The Quick Take
- What they studied: How scientists can improve the manufacturing process for vitamin B12 using bacteria and fermentation technology to make it cheaper and more efficient
- Who participated: This is a comprehensive review article analyzing research from the Tianjin Institute of Industrial Biotechnology and global vitamin B12 production methods, not a study with human participants
- Key finding: Current industrial production of B12 using microbial fermentation is limited by low yields, but new metabolic engineering strategies and improved fermentation technologies show promise for significantly increasing production efficiency
- What it means for you: Better B12 manufacturing could lead to lower prices and wider availability of this essential vitamin, particularly benefiting people in countries with limited access to B12-rich foods or supplements
The Research Details
This is a comprehensive review article, not an original research study. The authors systematically examined all available scientific literature and industrial practices related to vitamin B12 manufacturing. They analyzed how B12 is made using different bacterial strains, reviewed the chemical processes involved, and evaluated current fermentation technologies used in factories worldwide.
The review focused on four main areas: the different chemical forms of B12 (cyanocobalamin, methylcobalamin, adenosylcobalamin, and hydroxocobalamin), the specific bacteria used to produce it (like Pseudomonas denitrificans and Propionibacterium freudenreichii), the genetic engineering strategies being tested to improve production, and the actual fermentation equipment and methods used in industrial settings.
By synthesizing information from multiple sources and research teams, the authors created a complete picture of where B12 manufacturing stands today and where it’s heading in the future.
Review articles are important because they help scientists and industry leaders understand the current state of knowledge and identify gaps that need solving. In this case, understanding all available B12 manufacturing methods helps identify which approaches work best and which ones need improvement. This type of comprehensive analysis guides future research and helps companies decide which technologies to invest in.
This review was published in a peer-reviewed scientific journal (Advances in Biochemical Engineering/Biotechnology) and was conducted by researchers at a major research institute in China. The authors systematically examined existing research rather than conducting new experiments, which is the appropriate methodology for a review article. The comprehensiveness of the analysis—covering synthesis methods, bacterial strains, genetic engineering, and fermentation technologies—demonstrates thorough research.
What the Results Show
The review reveals that vitamin B12 production worldwide relies primarily on microbial fermentation using two main bacterial strains: Pseudomonas denitrificans and Propionibacterium freudenreichii. These bacteria naturally produce B12, and scientists grow them in large tanks to harvest the vitamin. However, the current production levels are relatively low, meaning factories don’t get as much B12 from each batch as they theoretically could.
The most commonly used form of B12 in industry is cyanocobalamin because it’s chemically stable and doesn’t break down easily during storage and transportation. While the human body can convert cyanocobalamin into other active forms it needs, this stability makes it the preferred choice for manufacturing and distribution.
The research identifies metabolic engineering—genetically modifying the bacteria to work more efficiently—as a promising solution to increase production. By adjusting which genes are active in these bacteria, scientists can make them produce more B12 with fewer resources. Additionally, improvements in fermentation technology (the equipment and processes used to grow the bacteria) show significant potential for boosting yields.
The review also highlights that the global B12 market is growing, driven by increasing demand from the pharmaceutical industry, animal feed production, food fortification programs, and cosmetic applications. This growing demand makes improving production efficiency increasingly important.
The review discusses how different forms of B12 have different advantages. Methylcobalamin and adenosylcobalamin are the active forms your body actually uses, while cyanocobalamin and hydroxocobalamin are converted by your body into these active forms. Understanding these differences helps manufacturers decide which form to produce based on market demand.
The analysis also examines cost control strategies in B12 production. As manufacturing becomes more efficient, the cost per unit of B12 decreases, making supplements and fortified foods more affordable. The review notes that China has become a major B12 producer, and understanding global market patterns helps predict future availability and pricing.
Another important finding is that fermentation technology continues to advance, with newer bioreactor designs allowing better control over growing conditions, which can improve bacterial productivity and reduce contamination risks.
This review builds on decades of research into B12 production. While B12 fermentation has been used industrially since the 1950s, production methods have continuously improved. The review shows that current research is moving beyond simply growing bacteria better toward actively engineering the bacteria themselves to be more productive. This represents an evolution from traditional fermentation toward synthetic biology approaches. The comprehensive analysis helps readers understand how far the field has come and what challenges remain compared to other vitamin manufacturing processes.
As a review article rather than original research, this work synthesizes existing knowledge but doesn’t present new experimental data. The review’s conclusions depend on the quality of the studies it examines. Additionally, because B12 manufacturing involves proprietary industrial processes, some cutting-edge techniques used by major manufacturers may not be fully documented in published research. The review focuses primarily on scientific and technical aspects rather than economic factors, so readers seeking detailed cost-benefit analyses may need additional sources. Finally, the rapid pace of biotechnology means some newer developments may not yet be reflected in published literature.
The Bottom Line
For consumers: Current B12 supplements and fortified foods are safe and effective; these manufacturing improvements will make them more affordable and accessible in the future. For people at risk of B12 deficiency (vegans, vegetarians, older adults, people with certain digestive conditions), continue using supplements or fortified foods as recommended by healthcare providers—don’t wait for improved manufacturing. For industry professionals: Investing in metabolic engineering and advanced fermentation technologies shows strong promise for improving production efficiency and reducing costs. The evidence supporting these approaches is solid and growing.
Anyone who takes B12 supplements or eats fortified foods should care about manufacturing improvements because they affect price and availability. People in developing countries with limited access to B12-rich foods or supplements will benefit most from cheaper production. Healthcare providers and public health officials should follow these developments because improved B12 availability could help address deficiency in vulnerable populations. Animal agriculture and food manufacturers care because B12 fortification is increasingly important for animal feed and processed foods.
Manufacturing improvements typically take 5-10 years to move from laboratory research to industrial implementation. Some improvements in fermentation efficiency could reach production facilities within 3-5 years. Cost reductions from improved manufacturing would likely become noticeable to consumers within 5-10 years as new technologies are adopted across the industry. The benefits of better B12 availability in developing countries may take longer, depending on infrastructure and economic factors.
Frequently Asked Questions
How is vitamin B12 made in factories?
B12 is manufactured using bacteria (primarily Pseudomonas denitrificans and Propionibacterium freudenreichii) grown in large fermentation tanks. These bacteria naturally produce B12, which is then harvested, purified, and processed into supplements and fortified foods.
Why do scientists want to improve B12 manufacturing?
Current production yields are relatively low, making B12 expensive to produce. Improving manufacturing efficiency through genetic engineering and better fermentation technology could significantly reduce costs, making B12 supplements and fortified foods more affordable and accessible worldwide.
What is cyanocobalamin and why is it used most?
Cyanocobalamin is one of four forms of vitamin B12. It’s the most commonly used in industry because it’s chemically stable and doesn’t break down during storage and transportation. Your body converts it into the active forms it needs.
When will cheaper B12 from better manufacturing reach consumers?
Manufacturing improvements typically take 5-10 years to move from research to industrial use. Some efficiency gains could reach production facilities within 3-5 years, with noticeable price reductions for consumers likely within 5-10 years as new technologies are adopted.
Who benefits most from improved B12 manufacturing?
People in developing countries with limited access to B12-rich foods or supplements will benefit most from cheaper production. Vegans, vegetarians, older adults, and people with digestive conditions who rely on supplements will also benefit from increased availability and lower costs.
Want to Apply This Research?
- Track your B12 intake by logging supplement doses (dosage and frequency) and noting any dietary sources of B12 consumed. Record energy levels, mood, and cognitive clarity weekly to monitor potential B12-related improvements over time.
- If you’re at risk for B12 deficiency, use the app to set reminders for daily or weekly B12 supplement doses. Log your consumption consistently to ensure you’re meeting recommended intake levels (typically 2.4 micrograms daily for adults).
- Establish a baseline of your current B12 intake and symptoms, then track consistently for 8-12 weeks. Monitor for improvements in energy, mood, and cognitive function. If you have a diagnosed B12 deficiency, track these metrics before and after starting supplementation to measure personal response.
This article reviews scientific research on vitamin B12 manufacturing processes and does not constitute medical advice. If you have symptoms of B12 deficiency (fatigue, weakness, numbness, cognitive changes), consult a healthcare provider for proper diagnosis and treatment. Do not self-diagnose or self-treat based on this information. Current B12 supplements and fortified foods are safe and effective; manufacturing improvements discussed here are for future optimization. Always follow your healthcare provider’s recommendations regarding B12 supplementation, especially if you have underlying health conditions or take medications that affect B12 absorption.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.